Singapore, March 19 -- UK-based Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations (Japanese corporate name Genesis Healthcare Co.), one of Japan's leading genetic testing companies, have announced an international collaboration to develop and deploy advanced genomic sequencing and medicine applications based on comprehensive, nanopore sequencing in Japan.

Published by HT Digital Content Services with permission from BioSpectrum Asia....